Proteins Powering Nexgen Healthcare | Quanterix

COVID-19
Simoa® Technology
Therapeutic Areas
Neurology Oncology Immunology/Inflammation Infectious Disease Cardiology
Products & Services
Simoa® Assay KitsReady-to-use Simoa® assay kits compatible with Quanterix instruments Simoa® SARS CoV-2 Antigen Assay (EUA)COVID-19 antigen test for qualitative detection of N protein antigen and permitted for use under FDA Emergency Use Authorization HD-X Analyzer™Our flagship automated immunoassay analyzer offering ultrasensitive biomarker measurement SR-X™ Biomarker Detection SystemBenchtop digital immunoassay platform delivering ultrasensitive biomarker detection in a compact instrument SP-X Imaging and Analysis System™Robust circulating biomarker detection in a benchtop multiplex immunoassay platform 2470 ArrayerFully automated microarray printer powered by proprietary soft touch deposition technology Simoa® Accelerator LaboratoryFull-service center for biomarker testing services and custom immunoassay development Uman NF-Light™NfL ELISA kits and antibodies for the detection of neurofilament light chain Homebrew – Custom Assay DevelopmentUltrasensitive immunoassay development solution providing flexibility for specialized research applications
Support & Resources
Customer Care & Technical Support Safety Data Sheets & Cert. of Analysis Product Brochures Whitepapers & App Notes Publications And Posters Conferences Webinars
Media Center
Press Releases Videos & Recordings In The News Blog
Company
Meet the Management Team Meet the Global Sales Team
Contact Us

Careers
Investors
Customer Portal
Search

back to conferences

Proteins Powering Nexgen Healthcare

date

29 October, 2015

location

San Francisco, CA

View agenda and register.

Share this page

stay tuned

Subscribe to our newsletter

info@quanterix.com

900 Middlesex TPKE
Billerica, MA 01821
USA

Investor Portal
Customer Portal
Contact Us

Terms and Conditions
Privacy Shield Statement

© 2021 Quanterix All rights reserved.

Privacy Policy

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

Agree Learn more